These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34716691)

  • 1. Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program.
    Wei Y; Luo H; Yee PP; Zhang L; Liu Z; Zheng H; Zhang L; Anderson B; Tang M; Huang S; Li W
    Adv Sci (Weinh); 2021 Dec; 8(24):e2102653. PubMed ID: 34716691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
    Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
    Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression.
    Lu Y; Wu T; Gutman O; Lu H; Zhou Q; Henis YI; Luo K
    Nat Cell Biol; 2020 Apr; 22(4):453-464. PubMed ID: 32203417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
    Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
    J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
    Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
    J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells.
    Yamamoto K; Goyama S; Asada S; Fujino T; Yonezawa T; Sato N; Takeda R; Tsuchiya A; Fukuyama T; Tanaka Y; Yokoyama A; Toya H; Kon A; Nannya Y; Onoguchi-Mizutani R; Nakagawa S; Hirose T; Ogawa S; Akimitsu N; Kitamura T
    Cell Rep; 2021 Aug; 36(8):109576. PubMed ID: 34433054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
    Escoll M; Lastra D; Pajares M; Robledinos-Antón N; Rojo AI; Fernández-Ginés R; Mendiola M; Martínez-Marín V; Esteban I; López-Larrubia P; Gargini R; Cuadrado A
    Redox Biol; 2020 Feb; 30():101425. PubMed ID: 31918259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
    J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
    Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
    Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
    Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
    Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ.
    Liu Z; Wei Y; Zhang L; Yee PP; Johnson M; Zhang X; Gulley M; Atkinson JM; Trebak M; Wang HG; Li W
    Oncogene; 2019 Jan; 38(1):120-139. PubMed ID: 30082911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
    Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
    BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.
    Zanconato F; Forcato M; Battilana G; Azzolin L; Quaranta E; Bodega B; Rosato A; Bicciato S; Cordenonsi M; Piccolo S
    Nat Cell Biol; 2015 Sep; 17(9):1218-27. PubMed ID: 26258633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer.
    Kiang KM; Ahad L; Zhong X; Lu QR
    Trends Cell Biol; 2024 Jul; 34(7):566-577. PubMed ID: 38806345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-binding protein p54
    Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
    Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.